[1]
“Damages for restraints on competition - a case of private enforcement in the pharmaceutical sector”, IN, vol. 11, no. 4, pp. 95–118, Dec. 2017, Accessed: Jan. 10, 2026. [Online]. Available: https://iusnovum.lazarski.pl/iusnovum/article/view/981